The content is available as a PDF (164.2 KB).
Footnotes
Disclosures
Funding source: none.
Conflicts of interest: none.
These authors contributed equally
References
- 1.Katsikas Triantafyllidis K, Giannos P, Mian IT, Kyrtsonis G, Kechagias KS. Varicella zoster virus reactivation following COVID-19 vaccination: a systematic review of case reports. Vaccines (Basel) 2021;9:1013–24. doi: 10.3390/vaccines9091013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Barda N, Dagan N, Ben-Shlomo Y, et al. Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting. N Engl J Med. 2021;385:1078–90. doi: 10.1056/NEJMoa2110475. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Chu CW, Jiesisibieke ZL, Yang YP, Wu PC, Lin HL, Tung TH. Association of COVID-19 vaccination with herpes zoster: a systematic review and meta-analysis. Expert Rev Vaccines. 2022;21:1–8. doi: 10.1080/14760584.2022.2036128. [DOI] [PubMed] [Google Scholar]
- 4.Diez-Domingo J, Parikh R, Bhavsar AB, Cisneros E, McCormick N, Lecrenier N. Can COVID-19 increase the risk of herpes zoster? A narrative review. Dermatol Ther (Heidelb) 2021;11:1119–26. doi: 10.1007/s13555-021-00549-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Aksu SB, Ozturk GZ. A rare case of shingles after COVID-19 vaccine: is it a possible adverse effect? Clin Exp Vaccine Res. 2021;10:198–201. doi: 10.7774/cevr.2021.10.2.198. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Psichogiou M, Samarkos M, Mikos N, Hatzakis A. Reactivation of varicella zoster virus after vaccination for SARS-CoV-2. Vaccines (Basel) 2021;9:572–9. doi: 10.3390/vaccines9060572. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Wanders SL, Loots MAM, Baak M. Risk factors for disseminated herpes zoster. Ned Tijdschr Geneeskd. 2020;164:D4825. [PubMed] [Google Scholar]